Select Page
FDA Approves First Prostate Cancer Hormone Treatment

FDA Approves First Prostate Cancer Hormone Treatment

Today (12/21) the U.S. Food and Drug Administration (FDA) approved the first oral treatment for prostate cancer, a disease that affects on average one in every nine men. Orgovyx, created by Myovant, was created to treat advanced prostate cancer cases by blocking the...
The European Medicines Agency (EMA) Suffers Cyber Attack

The European Medicines Agency (EMA) Suffers Cyber Attack

BioNTech released a statement on December 9, 2020 that Pfizer and their COVID-19 vaccine documents was “unlawfully accessed” in a breach on the European Medical Agency’s (EMA) system. The severity of the attack was not divulged, however the EMA disclosed that...
FDA Breakthrough Designation Given to ReGelTec

FDA Breakthrough Designation Given to ReGelTec

ReGelTec, a medical device company out of Baltimore’s leading medical device HYDRAFIL, has received Breakthrough Designation from the U.S. Food and Drug Administration (FDA). The Breakthrough Device Program was created with intentions to expedite the...